IEM is a researcher, developer and manufacturer of validated medical devices and services, specializing in the field of cardiovascular diseases.
The medium-sized family company based in Aachen, Germany has been in existence for over 25 years and is one of the leading providers in the premium segment internationally.
As an international technology expert for hypertension management, IEM offers complete solutions in the areas of screening, diagnostics and follow-up management.
In addition to these core products, the focus is on eHealth - an efficient therapy and compliance management of vital data recorded at home.
The Mobil-O-Graph® is considered as a classic among ABPM devices for use in doctors’ practices and clinics. Its intuitive combined with Hypertension Management Software (HMS) helps to increase the efficiency of day-to-day practice operations and have made the Mobil-O-Graph® one of the most popular long-term blood pressure measuring devices in diagnostics.
The clinically validated blood pressure monitor Tel-O-Graph® BT is the first measurement device on the market that can be used in two areas of application.
It can be used for screening in the doctor‘s office and clinic, as well as for telemedical home blood pressure and vascular age measurement.
The Tel-O-Graph® GSM is the most innovative and convenient solution available for digital blood pressure adjustment and continuous follow-up of blood pressure readings.
The user normally uses the system to measure their own blood pressure twice or three times daily from the comfort of home. Following measurement, the measured values are encrypted and automatically sent using mobile communication signals from the Tel-O-Graph® GSM to the Hypertension Management Software (HMS CS) or the telemedicine platform, in which it can be managed at the click of a button.
Comprehensive care for hypertension
Hypertension (high blood pressure) and its secondary diseases (heart disease, kidney failure, strokes, etc.) are the number one causes of death worldwide according to the World Health Organisation (WHO), with an anually mortality rate of 41 million.
There are more than 1.6 billion identified hypertensives globally, though the true figures are probably higher. There is also a need for action in helping uncontrolled hypertensives due to a lack of compliance or prescription of the wrong medication.